These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 32590022)
1. UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation. Yin H; Wang X; Zhang X; Zeng Y; Xu Q; Wang W; Zhou F; Zhou Y Cancer Lett; 2020 Dec; 494():121-131. PubMed ID: 32590022 [TBL] [Abstract][Full Text] [Related]
2. UBE2T promotes stage I lung adenocarcinoma progression through PBX1 ubiquitination and PBX1/RORA regulation. Deng Y; Chen X; Chen X; Huang C; Zhang Z; Xu Z; Wang X; Wu J; Li L; Song J; Zhou R BMC Cancer; 2024 Sep; 24(1):1158. PubMed ID: 39289660 [TBL] [Abstract][Full Text] [Related]
3. UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT. Zhang J; Wang J; Wu J; Huang J; Lin Z; Lin X Oncol Rep; 2022 Aug; 48(2):. PubMed ID: 35703356 [TBL] [Abstract][Full Text] [Related]
4. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation. Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136 [TBL] [Abstract][Full Text] [Related]
5. UBE2T knockdown inhibits gastric cancer progression. Luo C; Yao Y; Yu Z; Zhou H; Guo L; Zhang J; Cao H; Zhang G; Li Y; Jiao Z Oncotarget; 2017 May; 8(20):32639-32654. PubMed ID: 28427240 [TBL] [Abstract][Full Text] [Related]
6. UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT. Huang P; Guo Y; Zhao Z; Ning W; Wang H; Gu C; Zhang M; Qu Y; Zhang H; Song Y Aging (Albany NY); 2020 Jun; 12(11):10275-10289. PubMed ID: 32491994 [TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53. Wu M; Li X; Huang W; Chen Y; Wang B; Liu X Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway. Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p. Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764 [TBL] [Abstract][Full Text] [Related]
10. FOXO1 Inhibits Tumor Cell Migration via Regulating Cell Surface Morphology in Non-Small Cell Lung Cancer Cells. Gao Z; Liu R; Ye N; Liu C; Li X; Guo X; Zhang Z; Li X; Yao Y; Jiang X Cell Physiol Biochem; 2018; 48(1):138-148. PubMed ID: 30001537 [TBL] [Abstract][Full Text] [Related]
11. Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and invasion by inhibiting G9a in non-small-cell lung cancer A549 cells. Zhang L; Liang B; Xu H; Gong Y; Hu W; Jin Z; Wu X; Chen X; Li M; Shi L; Shi Y; Wang Y; Yang L J Ethnopharmacol; 2022 Jun; 291():115095. PubMed ID: 35176466 [TBL] [Abstract][Full Text] [Related]
12. FBW7 loss promotes epithelial-to-mesenchymal transition in non-small cell lung cancer through the stabilization of Snail protein. Zhang Y; Zhang X; Ye M; Jing P; Xiong J; Han Z; Kong J; Li M; Lai X; Chang N; Zhang J; Zhang J Cancer Lett; 2018 Apr; 419():75-83. PubMed ID: 29355657 [TBL] [Abstract][Full Text] [Related]
13. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
14. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer. Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281 [TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway. Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091 [TBL] [Abstract][Full Text] [Related]
16. Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer. Wang B; Tang Z; Gong H; Zhu L; Liu X Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054966 [TBL] [Abstract][Full Text] [Related]
17. CUEDC1 inhibits epithelial-mesenchymal transition via the TβRI/Smad signaling pathway and suppresses tumor progression in non-small cell lung cancer. Cui Y; Song Y; Yan S; Cao M; Huang J; Jia D; Liu Y; Zhang S; Fan W; Cai L; Li C; Xing Y Aging (Albany NY); 2020 Oct; 12(20):20047-20068. PubMed ID: 33099540 [TBL] [Abstract][Full Text] [Related]
18. BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway. Zhang Y; Zhang Q; Chen H; Wang C Life Sci; 2018 Sep; 208():284-294. PubMed ID: 30009824 [TBL] [Abstract][Full Text] [Related]
19. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway. Hu W; Xiao L; Cao C; Hua S; Wu D Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]